The role of exercise in cardiovascular rehabilitation: A review

Acta Cardiologica

Volumn 63, Issue 1, 2008, Pages 73-79

  Koutroumpi, Matina ^a   Pitsavos, Christos ^a   Stefanadis, Christodoulos ^a   Koutroumpi, Stamatina ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Cardiovascular; Diabetes; Exercise; Hypertension

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD CLOTTING; BLOOD PRESSURE; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET THERAPY; DYSLIPIDEMIA; ENDURANCE; EXERCISE INTENSITY; HEART FAILURE; HEART STROKE VOLUME; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 39349096939     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.1.2025335     Document Type: Review

References (64)

1. Brown MD. Exercise and coronary vascular remodeling in the healthy heart. Exp Physiol 2003; 88; 645-58.
2. Duscha BD, Slentz CA, Johnson, JL, Hoummard JA, Bensimhon DR, Knetzger KJ, Kraus WE. Effects of exercise training amount and intensity on peak oxygen consumption in middle-aged men and women at risk for cardiovascular disease. Chest 2005; 128; 2788-93.
3. U.S. Department of Health and Human Services. Physical activity and health: a report of the surgeon general, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
4. ACSM's guidelines for exercise testing and prescription. Sixth edition. Lippincott Williams and Wilkins, Philadelphia, 2000.
5. Durstine JL, Moore GE. ACSM's exercise management for persons with chronic diseases and disabilities. Second edition. Human kinetics, American College of Sports Medicine, PO Box 5076, J. Champaign IL, 2003.
6. Kokkinos PF, Papademetriou V. Exercise and hypertension. Coron Artery Dis 2000; 11: 99-102.
7. Hagberg JM, Park JJ, Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med 2000; 30: 193-206.
8. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA; American College of Sports Medicine. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533-53.
9. Pescatello LS. Exercise and hypertension: recent advances in exercise prescription. Curr Hypertens Rep 2005; 7: 281-6.
10. Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Cambell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Cambell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Lapochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Garruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gleghill N, Petrella R, Tobe S, Touyz RM. The 2006 Canadian Hypertension Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol 2006; 22: 583-93.
11. Pitsavos C, Milias GA, Panagiotakos DB, Xenaki D, Panagopoulos G, Stefanadis C. Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition and health survey in Greece. BMC Public Health 2006; 6: 206.
12. Stone NJ. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes. Clin Cornerstone 2006; 8 Suppl 1:S15-20
13. Konig D, Deibert P, Dickhuth HH, Berg A. Physical activity and dyslipoproteinemia. MMW Fortschr Med 2004; 146: 34-7 (in German).
14. Marinangeli CP, Varady KA, Jones PJ. Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergic mechanisms of action. J Nutr Biochem 2006; 17: 217-24.
15. Pejic RN, Lee DT Hypertriglyceridemia. JABFM 2006; 19: 310-6.
16. Tokmakidis SP, Volaklis KA. Training and detraining effects of combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease. J Cardiopulm Rehabil 2003; 23: 193-200.
17. Gill JM, Herd SL, Vora V, Hardman AE. Effects of a brisk walk on lipoprotein lipase activity and plasma triglyceride concentrations in the fasted and postprandial states. Eur J Appl Physiol 2003; 89: 184-90.
18. Herd SL, Kiens B, Boobis LH, Hardman AE. Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity. Metabolism 2001; 50: 756-62.
19. rd, Szmedra L. Age and gender related trends in body composition, lipids and exercise capacity during cardiac rehabilitation. Am J Geriatr Cardiol 1997; 6: 37-45.
20. Gao YX, Xian J. Study of effective antiobesity in diet and physical exercise for patients with simple obesity. Zhonghua Zheng Xing Wai Ke Za Zhi 2006; 22: 365-7.
21. U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation. Physical activity fundamental to preventing disease. U.S. Department of Health and Human Services, Washington, June 20, 2002.
22. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530-8.
23. Calling S, Hedblad B, Engstrom G, Berglund G, Janzon L. Effects of body fatness and physical activity on cardiovascular risk: risk prediction using the bioelectrical impedance method. Scand J Public Health 2006; 34: 568-75.
24. Vainio H, Bianchini F, Eds. Weight control and physical activity. IARC Handbooks of Cancer Prevention. IARC Press, Lyon, France, 2002; volume 6.
25. U.S. Department of Health and Human Services. The Surgeon General's call to action to prevent and decrease overweight and obesity. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
26. Martinez MC, Latorre Mdo R. Risk factors for hypertension and diabetes mellitus in metallurgic and siderurgic company's workers. Arq Bras Cardiol 2006; 87: 471-9.
27. Boursier V. Metabolic syndrome. J Mal Vasc 2006; 31 (4 pt 1): 190-201.
28. Karnehed N, Tynelius P, Heitmann BL, Rasmussen F. Physical activity, diet and gene-environment interactions in relation to body mass index and waist circumference: the Swedish young male twins study. Public Health Nutr 2006; 9: 821-2.
29. Shaw K, Gennat H, O'Rourke P, Del Marc C. Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; 4: CD003817.
30. Arciero PJ, Gentile C, Martin-Pressman R, Ormsbee MJ, Everett M, Zwicky L, Steele CA. Increased dietary protein and combined high intensity aerobic and resistance exercise improves body fat distribution and cardiovascular risk factors. Int J Sports Nutr Exerc Metab 2006; 16: 373-92.
31. Skerrett PJ, Manson JE. Reduction in risk of coronary heart disease and diabetes. Handbook of Exercise in Diabetes. American Diabetes Association. 2002. American Diabetes Association, Alexandria, VA.
32. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol 2005; 99: 1193-1204.
33. Shork KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, Nair KS. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52: 1888-96.
34. Wannamethee SG, Shaper AG, Alberti KG. Physical activity metabolic factors and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med 2000; 160: 2108-16.
35. Mayers-Davis EJ, D'Agostino RJ, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 1998; 279: 669-74.
36. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, and Study Group DECODE. Prevalence of the metabolic syndrome and its relation to all-cause mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-76.
37. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
38. Ridker PM. C-reactive protein and risks for future myocardial infarction and thrombotic stroke. Eur Heart J 1998; 19: 1-3.
39. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. Creactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-5.
40. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilah EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol 1997; 17: 1121-7.
41. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-82.
42. Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286-92.
43. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002; 13: 561-8.
44. King DE, Carek P, Mainous III AG, Pearson WS. Inflammatory markers and exercise: differences related to exercise type. Med Sci Sports Exerc 2003; 35: 575-81.
45. Pitsavos C, Chrysohoou C, Panagiotakos DB, Skoumas J, Zeimbekis A, Kokkinos P, Stefanadis C, Toutouzas PK. Association of leisure time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol 2003; 91: 368-70.
46. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C. The associations between leisure time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA study. Eur J Cardiovasc Prev Rehabil 2005; 12: 151-8.
47. MacAuley D, McCrum EE, Scott G, Evans AE, Mc Roberts B, Boreham CA, Sweeney K, Trinick TR. Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey. J Epidemiol Community Health 1996; 50: 258-63.
48. Assanelli D, Bersatti F, Ferrari R, Bollani G, Ferrari M, Ballardini E, Guerra GP, Parrinello G. Effect of leisure time and working activity on principal risk factors and relative interactions in active middle-aged men. Coron Artery Dis 1999; 10: 1-7.
49. Eliasson M, Asplund K, Evrin PE. Regular leisure time physical activity predicts high activity of tissue plasminogen activator: the Northern Sweden MONICA study. Int J Epidemiol 1996; 25: 1182-7.
50. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998; 81: 18B-25B.
51. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001; 285: 2486-97.
52. Das UN. Metabolic syndrome X: an inflammatory condition? Curr Hypertens Rep 2004; 6: 66-73.
53. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C. The association between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovasc Prev Rehabil 2005; 12:151-8.
54. Hambrecht R, Niebauer R, Marburger C, Grunze M, Kalberer B, Hauer K, Schlierf G, Kubler W, Schuler G. Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993; 22: 468-77.
55. Laughlin MH. Effects of exercise training on coronary circulation: introduction. Med Sc Sports Exer 1994; 26: 1226-9.
56. Prior BM, Yang HT, Terjung RL. What makes vessels grow with exercise training? J Appl Physiol 2004; 97: 1119-28.
57. Hambrecht R. Stress and stress tolerance in chronic heart failure. Herz 2002; 27: 179-86.
58. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, Schoene N, Schuler G. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA 2000; 283: 3095-101.
59. Gielen S, Erbs S, Schuler G, Hambrecht R. Exercise training and endothelial dysfunction in coronary artery disease and chronic heart failure. From molecular biology to clinical benefits. Minerva Cardioangiol 2002; 50: 95-106.
60. Erbs S, Linke A, Gielen S, Fiehn E, Walther C, Yu J, Adams V, Schuler G, Hambrecht R. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Trial. Eur J Cardiovasc Prev Rehabil 2003; 10: 336-44.
61. Huonker M, Keul J. Value of training-induced effects on arterial vascular system and skeletal muscles in therapy of NYHA II/III heart failure. Z Kardiol 2001; 90: 813-23 (in German).
62. McConnell TR, Mandak JS, Fesniak H, Dasgupta H. Exercise training for heart failure patients improves respiratory muscle endurance, exercise tolerance, breathlessness and quality of life. J Cardiopulm Rehabil 2003; 23: 10-6.
63. Gielen S, Adams V, Linke A, Erbs S, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R. Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur J Cardiovasc Prev Rehabil 2005; 12: 393-400.
64. Volaklis KA, Tokmakidis SP. Resistance exercise training in patients with heart failure. Sports Med 2005; 35: 1085-103.